UnitedHealth Group (UNH)
(Real Time Quote from BATS)
$604.53 USD
-10.14 (-1.65%)
Updated Nov 13, 2024 02:12 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
UNH 604.53 -10.14(-1.65%)
Will UNH be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for UNH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for UNH
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal
UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It
UNH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stocks and ETFs in Focus as Americans Head to Polls
Encompass Health Q3 Earnings Beat on Higher Discharges, Stock Up 6.3%
Ensign Group Q3 Earnings Beat on Patient Days, Stock Up 4.1%
Other News for UNH
Myriad Genetics price target lowered to $24 from $34 at Scotiabank
Rock Springs Capital Management LP Acquires Significant Stake in Mereo BioPharma Group PLC
Myriad Genetics price target lowered by $10 at Scotiabank, here's why
DOJ, state AGs sue to block UnitedHealth’s acquisition of Amedisys
DOJ, state AGs sue to block UnitedHealth's acquisition of Amedisys